新发炎症性肠病老年人的衰弱患病率及其意义:一项全国性队列研究
这项瑞典全国性队列研究纳入2007至2016年新发炎症性肠病且年龄≥60岁的患者10590例,并与103398名匹配对照比较。炎症性肠病患者的医院衰弱风险评分均值高于对照;在炎症性肠病队列中,较高衰弱风险与死亡和住院风险增加相关,调整合并症后关联未减弱。
要点
- 炎症性肠病患者中39%无衰弱风险、49%低风险、12%较高风险,评分均值1.9高于对照的0.9(P<.01)。
- 较高衰弱风险者3年死亡风险较无衰弱者高20%,死亡HR 3.22(95%CI 2.86-3.61)。
- 较高衰弱风险与全因住院(HR 2.42)及炎症性肠病相关住院(HR 1.50)风险增加相关,调整合并症后未减弱。
核心结论
- 炎症性肠病老年人的衰弱较匹配对照更常见。
- 在老年炎症性肠病患者中,衰弱与住院和死亡风险增加相关。
研究设计与样本
- 基于瑞典全国登记数据的新发炎症性肠病且年龄≥60岁患者队列,2007至2016年。
- 共纳入10590例炎症性肠病患者,52%为女性,平均年龄71岁,匹配103398名基于人群的对照。
- 使用医院衰弱风险评分定义衰弱,比较炎症性肠病患者与按年龄、性别、居住地和日历年匹配的对照的衰弱患病率。
- 在炎症性肠病队列中使用Cox比例风险模型分析衰弱风险与住院或死亡的关联。
主要发现
- 炎症性肠病患者中39%无衰弱风险、49%低风险、12%较高风险;医院衰弱风险评分均值炎症性肠病为1.9 vs 匹配对照为0.9(P<.01)。
- 较高衰弱风险的老年炎症性肠病患者3年死亡风险较无衰弱者高20%。
- 较高衰弱风险者较无衰弱者死亡风险增加(HR 3.22,95%CI 2.86-3.61)。
- 较高衰弱风险者较无衰弱者全因住院风险增加(HR 2.42,95%CI 2.24-2.61)。
- 较高衰弱风险者较无衰弱者炎症性肠病相关住院风险增加(HR 1.50,95%CI 1.35-1.66)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: We aimed to compare the risk of frailty in older adults with incident inflammatory bowel disease (IBD) and matched non-IBD comparators and assess the association between frailty and future hospitalizations and mortality. METHODS: In a cohort of patients with incident IBD ≥60 years of age from 2007 to 2016 in Sweden identified using nationwide registers, we defined frailty using Hospital Frailty Risk Score. We compared prevalence of frailty in patients with IBD with age, sex, place of residency- and calendar year-matched population comparators. In the IBD cohort, we used Cox proportional hazards modeling to examine the associations between frailty risk and hospitalizations or mortality. RESULTS: We identified 10,590 patients with IBD, 52% female with a mean age of 71 years of age, matched to 103,398 population-based comparators. Among patients with IBD, 39% had no risk for frailty, 49% had low risk for frailty, and 12% had higher risk for frailty. Mean Hospital Frailty Risk Score was 1.9 in IBD and 0.9 in matched comparators (P < .01). Older adults with IBD at higher risk for frailty had a 20% greater risk for mortality at 3 years compared with those who were not frail. Compared with nonfrail older patients with IBD, patients at higher risk for frailty had increased mortality (hazard ratio [HR], 3.22, 95% confidence interval [CI], 2.86-3.61), all-cause hospitalization (HR, 2.42; 95% CI, 2.24-2.61), and IBD-related hospitalization (HR, 1.50; 95% CI, 1.35-1.66). These associations were not attenuated after adjusting for comorbidities. CONCLUSIONS: Frailty is more prevalent in older adults with IBD than in matched comparators. Among older patients with IBD, frailty is associated with increased risk for hospitalizations and mortality.
引用
- Kochar B, Jylhävä J, Söderling J, et al. Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study. Clin Gastroenterol Hepatol. 2022. PMID: 34999206. doi:10.1016/j.cgh.2022.01.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。